{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:06:56Z","timestamp":1792627616544,"version":"4.5.0"},"reference-count":67,"publisher":"ARAN Ediciones","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.hipert.2021.01.002","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T21:11:27Z","timestamp":1614028287000},"page":"133-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Tratamiento farmacol\u00f3gico de la hipertensi\u00f3n arterial no severa durante el embarazo, el posparto y la lactancia"],"prefix":"10.20960","volume":"38","author":[{"given":"A.M.","family":"Ghelfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.","family":"Staffieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8588","reference":[{"key":"10.1016\/j.hipert.2021.01.002_bib0340","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J."},{"key":"10.1016\/j.hipert.2021.01.002_bib0345","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health."},{"key":"10.1016\/j.hipert.2021.01.002_bib0350","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.hipert.2018.06.001","article-title":"Utilidad del \u00edndice neutr\u00f3filo\/linfocito y del \u00edndice polimorfonuclear\/monomorfonuclear, en la predicci\u00f3n de preeclampsia","volume":"36","author":"Ghelfi","year":"2019","journal-title":"Hipertens Riesgo Vasc."},{"key":"10.1016\/j.hipert.2021.01.002_bib0355","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.rccl.2019.10.004","article-title":"Recomendaciones de seguimiento a partir del \u00abcuarto trimestre\u00bb de mujeres con complicaciones vasculares y metab\u00f3licas durante el embarazo. Documento de consenso de la SEC, SEMERGEN, semFYC y SEGO","volume":"55","author":"Castro-Conde","year":"2020","journal-title":"Rec Cardioclinics."},{"key":"10.1016\/j.hipert.2021.01.002_bib0360","year":"2019","journal-title":"Hypertension in pregnancy: diagnosis and management NICE guideline."},{"key":"10.1016\/j.hipert.2021.01.002_bib0365","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.hipert.2021.01.002_bib0370","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.preghy.2014.01.003","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"4","author":"Magee","year":"2014","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.hipert.2021.01.002_bib0375","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"ACOG Practice Bulletin Number 203: Chronic Hypertension in Pregnancy","volume":"133","year":"2019","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0380","first-page":"1","article-title":"Consenso Argentino de Hipertensi\u00f3n Arterial","volume":"86","year":"2018","journal-title":"Rev Argent Cardiol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0385","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0390","year":"2018","journal-title":"Hipertensi\u00f3n en la Mujer"},{"key":"10.1016\/j.hipert.2021.01.002_bib0395","series-title":"Hipertensi\u00f3n Arterial","first-page":"341","article-title":"Cap\u00edtulo 70 Medici\u00f3n de la presi\u00f3n arterial","author":"Blanco","year":"2013"},{"key":"10.1016\/j.hipert.2021.01.002_bib0400","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/HYPERTENSIONAHA.117.10295","article-title":"Accuracy of blood pressure measurement devices in pregnancy: a systematic review of validation studies","volume":"71","author":"Bello","year":"2018","journal-title":"Hypertension."},{"key":"10.1016\/j.hipert.2021.01.002_bib0405","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1471-0528.2004.00516.x","article-title":"The natural history of white coat hypertension during pregnancy","volume":"112","author":"Brown","year":"2005","journal-title":"BJOG."},{"key":"10.1016\/j.hipert.2021.01.002_bib0410","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","article-title":"Use of medication for cardiovascular disease during pregnancy: JACC State-of-the-Art Review","volume":"73","author":"Halpern","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0415","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1161\/CIR.0000000000000772","article-title":"Cardiovascular considerations in caring for pregnant patients. A scientific statement from the American Heart Association","volume":"141","author":"Mehta","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.hipert.2021.01.002_bib0420","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/CIRCULATIONAHA.115.019510","article-title":"Post partum hypertension: \u00abIt ain\u2019t over\u2019til it's over\u00bb","volume":"132","author":"August","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.hipert.2021.01.002_bib0425","doi-asserted-by":"crossref","first-page":"E913","DOI":"10.1503\/cmaj.160785","article-title":"Postpartum hypertension","volume":"189","author":"Powles","year":"2017","journal-title":"CMAJ."},{"key":"10.1016\/j.hipert.2021.01.002_bib0430","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"10","author":"Abalos","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.hipert.2021.01.002_bib0435","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.hipert.2021.01.002_bib0440","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1889-1837(18)30071-0","article-title":"La hipertensi\u00f3n arterial en la embarazada","volume":"34","author":"Martell-Claros","year":"2017","journal-title":"Hipertens Riesgo Vasc."},{"key":"10.1016\/j.hipert.2021.01.002_bib0445","first-page":"364","article-title":"Actualizaci\u00f3n del uso de f\u00e1rmacos durante el embarazo: categor\u00edas de riesgo","volume":"38","author":"Gallego-\u00dabeda","year":"2014","journal-title":"Farm Hosp."},{"key":"10.1016\/j.hipert.2021.01.002_bib0450","series-title":"Hipertensi\u00f3n Arterial","first-page":"542","article-title":"Cap\u00edtulo 115 F\u00e1rmacos simpaticol\u00edticos centrales y perif\u00e9ricos","author":"Altamirano","year":"2013"},{"key":"10.1016\/j.hipert.2021.01.002_bib0455","series-title":"Hipertensi\u00f3n Arterial","first-page":"625","article-title":"Cap\u00edtulo 132 Terap\u00e9utica de la hipertensi\u00f3n arterial cr\u00f3nica en el embarazo","author":"P\u00e1ez","year":"2013"},{"key":"10.1016\/j.hipert.2021.01.002_bib0460","series-title":"Hipertensi\u00f3n en el embarazo","author":"Voto","year":"2008"},{"key":"10.1016\/j.hipert.2021.01.002_bib0465","series-title":"Hipertensi\u00f3n Arterial","first-page":"534","article-title":"Cap\u00edtulo 113 Rol de los betabloqueadores en la terap\u00e9utica actual de la hipertensi\u00f3n arterial","author":"Gallo","year":"2013"},{"key":"10.1016\/j.hipert.2021.01.002_bib0470","series-title":"Hipertensi\u00f3n Arterial","first-page":"564","article-title":"Cap\u00edtulo 119 Antagonistas c\u00e1lcicos","author":"Bendersky","year":"2013"},{"key":"10.1016\/j.hipert.2021.01.002_bib0475","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1524-6175.2006.04482.x","article-title":"Calcium channel blocker class heterogeneity: select aspects of pharmacokinetics and pharmacodynamics","volume":"7","author":"Sica","year":"2005","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"10.1016\/j.hipert.2021.01.002_bib0480","unstructured":"Servizo Galego de Sa\u00fade. Xunta de Galicia. Conseller\u00eda de Sanidade. Nifedipino. Ficha de Productos https:\/\/www.sergas.es\/Asistencia-sanitaria\/Documents\/267\/NICARDIPINO.pdf"},{"key":"10.1016\/j.hipert.2021.01.002_bib0485","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.semperi.2015.08.011","article-title":"A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy","volume":"39","author":"Clark","year":"2015","journal-title":"Semin Perinatol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0490","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(19)31282-6","article-title":"Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial","volume":"394","author":"Easterling","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.hipert.2021.01.002_bib0495","unstructured":"Administraci\u00f3n Nacional de Medicamentos Alimentos y Tecnolog\u00eda M\u00e9dica (ANMAT). Ministerio de Salud Presidencia de la Naci\u00f3n Argentina. Nifedipino. Vadem\u00e9cum Nacional de Medicamentos https:\/\/servicios.pami.org.ar\/vademecum\/views\/consultaPublica\/listado.zul"},{"key":"10.1016\/j.hipert.2021.01.002_bib0500","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/HJH.0000000000001456","article-title":"In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review","volume":"35","author":"Fitton","year":"2017","journal-title":"J Hypertens."},{"key":"10.1016\/j.hipert.2021.01.002_bib0505","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2125.2011.04002.x","article-title":"How to manage hypertension in pregnancy effectively","volume":"72","author":"Magee","year":"2011","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0510","first-page":"S1","volume":"30","author":"Magee","year":"2008","journal-title":"Diagnosis evaluation, and management of the hypertensive disorders of pregnancy"},{"key":"10.1016\/j.hipert.2021.01.002_bib0515","doi-asserted-by":"crossref","first-page":"e013495","DOI":"10.1161\/JAHA.119.013495","article-title":"Safety of antihypertensive medications in pregnancy: living with uncertainty","volume":"8","author":"Malha","year":"2019","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.hipert.2021.01.002_bib0520","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/10641955.2016.1231317","article-title":"Oral labetalol compared to oral nifedipine for postpartum hypertension: A randomized controlled trial","volume":"36","author":"Sharma","year":"2017","journal-title":"Hypertens Pregnancy."},{"key":"10.1016\/j.hipert.2021.01.002_bib0525","first-page":"87","article-title":"Farmacoterapia durante el embarazo","volume":"31","author":"Sosa","year":"2009","journal-title":"Arch Med Int."},{"key":"10.1016\/j.hipert.2021.01.002_bib0530","first-page":"5488","article-title":"Tratamiento de la hipertensi\u00f3n arterial en situaciones especiales","volume":"11","author":"Bl\u00e1zquez-Collado","year":"2015","journal-title":"Medicine."},{"key":"10.1016\/j.hipert.2021.01.002_bib0535","series-title":"Hipertensi\u00f3n Arterial","first-page":"570","article-title":"Cap\u00edtulo 120 Vasodilatadores directos","author":"Bendersky","year":"2013"},{"key":"10.1016\/j.hipert.2021.01.002_bib0540","series-title":"Biblioteca de Obstetricia Cr\u00edtica: Tomo III. Preeclampsia Grave y Eclampsia.","author":"Malvino","year":"2018"},{"key":"10.1016\/j.hipert.2021.01.002_bib0545","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10641950701204554","article-title":"Exposure to amlodipine in the first trimester of pregnancy and during breastfeeding","volume":"26","author":"Ahn","year":"2007","journal-title":"Hypertens Pregnancy."},{"key":"10.1016\/j.hipert.2021.01.002_bib0550","doi-asserted-by":"crossref","first-page":"S515","DOI":"10.1016\/j.ajog.2016.11.812","article-title":"Pharmacokinetics of amlodipine besylate during pregnancy: how much infant exposure occurs?","volume":"216","author":"Morgan","year":"2017","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0555","doi-asserted-by":"crossref","first-page":"e012093","DOI":"10.1161\/JAHA.119.012093","article-title":"Safety of amlodipine in early pregnancy","volume":"8","author":"Mito","year":"2019","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.hipert.2021.01.002_bib0560","article-title":"Chronic Hypertension and Pregnancy (CHAP) Project (CHAP)","year":"2020","journal-title":"ClinicalTrials.gov."},{"key":"10.1016\/j.hipert.2021.01.002_bib0565","first-page":"160e1","article-title":"Gu\u00eda ESC\/ESH 2018 sobre el diagn\u00f3stico y tratamiento de la hipertensi\u00f3n arterial","volume":"72","year":"2019","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0570","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/01443615.2011.579197","article-title":"Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers","volume":"31","author":"Walfisch","year":"2011","journal-title":"J Obstet Gynaecol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0575","doi-asserted-by":"crossref","first-page":"d5931","DOI":"10.1136\/bmj.d5931","article-title":"Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study","volume":"343","author":"Li","year":"2011","journal-title":"BMJ."},{"key":"10.1016\/j.hipert.2021.01.002_bib0580","doi-asserted-by":"crossref","first-page":"k478","DOI":"10.1136\/bmj.k478","article-title":"Pregnancy in women with congenital heart disease","volume":"360","author":"Cauldwell","year":"2018","journal-title":"BMJ."},{"key":"10.1016\/j.hipert.2021.01.002_bib0585","series-title":"Gu\u00eda Pr\u00e1ctica. Uso de f\u00e1rmacos en el embarazo","first-page":"64","author":"Ruoti-Cosp","year":"2008"},{"key":"10.1016\/j.hipert.2021.01.002_bib0590","first-page":"20","article-title":"Curso b\u00e1sico sobre hipertensi\u00f3n: Tema 4 Betabloqueadores","volume":"31","author":"Mart\u00ednez-Rodr\u00edguez","year":"2017","journal-title":"Farm Prof."},{"key":"10.1016\/j.hipert.2021.01.002_bib0595","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejogrb.2016.07.509","article-title":"Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study)","volume":"206","author":"Vidler","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0600","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4067\/S0717-75262017000200013","article-title":"Hipertensi\u00f3n\/preeclampsia postparto. Recomendaciones de manejo seg\u00fan escenarios cl\u00ednicos, seguridad en la lactancia materna, una revisi\u00f3n de la literatura","volume":"82","author":"Ortiz-Mart\u00ednez","year":"2017","journal-title":"Rev chil obstet ginecol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0605","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajog.2011.09.002","article-title":"Etiology and management of postpartum hypertension-preeclampsia","volume":"206","author":"Sibai","year":"2012","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0610","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.hipert.2020.05.003","article-title":"S\u00edndrome HELLP: caracter\u00edsticas cl\u00ednicas, anal\u00edticas y evolutivas observadas en dos a\u00f1os de experiencia","volume":"37","author":"Ghelfi","year":"2020","journal-title":"Hipertens Riesgo Vasc."},{"key":"10.1016\/j.hipert.2021.01.002_bib0615","article-title":"Amlodipino","year":"2018","journal-title":"e-lactancia.org."},{"key":"10.1016\/j.hipert.2021.01.002_bib0620","article-title":"Atenolol","year":"2018","journal-title":"e-lactancia.org."},{"key":"10.1016\/j.hipert.2021.01.002_bib0625","doi-asserted-by":"crossref","first-page":"211","DOI":"10.31403\/rpgo.v55i294","article-title":"Miocardiopat\u00eda periparto y edema agudo pulmonar","volume":"55","author":"Razzeto-R\u00edos","year":"2009","journal-title":"Rev Peru Ginecol y Obstet."},{"key":"10.1016\/j.hipert.2021.01.002_bib0630","article-title":"Enalapril","year":"2018","journal-title":"e-lactancia.org."},{"key":"10.1016\/j.hipert.2021.01.002_bib0635","article-title":"Losart\u00e1n","year":"2018","journal-title":"e-lactancia.org."},{"key":"10.1016\/j.hipert.2021.01.002_bib0640","article-title":"Espironolactona","year":"2014","journal-title":"e-lactancia.org."},{"key":"10.1016\/j.hipert.2021.01.002_bib0645","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1586\/erc.11.98","article-title":"Stroke in pregnant and postpartum women","volume":"9","author":"Sidorov","year":"2011","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"10.1016\/j.hipert.2021.01.002_bib0650","first-page":"858134","article-title":"Preeclampsia and Stroke: Risks during and after Pregnancy","volume":"2011","author":"Bushnell","year":"2011","journal-title":"Stroke Res Treat."},{"key":"10.1016\/j.hipert.2021.01.002_bib0655","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1586\/ern.09.126","article-title":"Management of stroke in pregnancy and the puerperium","volume":"10","author":"Tang","year":"2010","journal-title":"Expert Rev Neurother."},{"key":"10.1016\/j.hipert.2021.01.002_bib0660","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bpobgyn.2019.03.008","article-title":"Postpartum care of women with renal disease","volume":"57","author":"Pillay","year":"2019","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"10.1016\/j.hipert.2021.01.002_bib0665","first-page":"4837","article-title":"S\u00edndromes renales. Criterios fisiopatol\u00f3gicos y formas cl\u00ednicas","volume":"11","author":"De Arriba","year":"2015","journal-title":"Medicine."},{"key":"10.1016\/j.hipert.2021.01.002_bib0670","unstructured":"Asociaci\u00f3n para la Promoci\u00f3n e Investigaci\u00f3n cient\u00edfica y cultural de la Lactancia Materna. Disponible en: http:\/\/www.e-lactancia.org\/"}],"container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183721000131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183721000131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:15:20Z","timestamp":1784596520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1889183721000131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1889183721000131"],"URL":"https:\/\/doi.org\/10.1016\/j.hipert.2021.01.002","relation":{},"ISSN":["1889-1837"],"issn-type":[{"value":"1889-1837","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tratamiento farmacol\u00f3gico de la hipertensi\u00f3n arterial no severa durante el embarazo, el posparto y la lactancia","name":"articletitle","label":"Article Title"},{"value":"Hipertensi\u00f3n y Riesgo Vascular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hipert.2021.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 SEH-LELHA. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}